These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 24648810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus.
    Hoang S, Pujar T, Bellorin-Font E, Edwards JC, Miyata KN.
    CEN Case Rep; 2024 Jun; 13(3):194-198. PubMed ID: 37897631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient.
    Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E.
    Nephrol Dial Transplant; 1998 Jun; 13(6):1547-9. PubMed ID: 9641191
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ifosfamide-induced nephrogenic diabetes insipidus and Fanconi syndrome in a patient with femur osteosarcoma.
    Concepción-Zavaleta M, Ramos-Torres G, Quiroz-Aldave J, Del Carmen Durand-Vásquez M, Ildefonso-Najarro S, de Jesús Alvarado-León E, Zavaleta-Gutiérrez F, Concepción-Urteaga L, Paz-Ibarra J.
    Caspian J Intern Med; 2024 Jun; 15(4):743-747. PubMed ID: 39359431
    [Abstract] [Full Text] [Related]

  • 9. Concentrating capacity in ifosfamide-induced severe renal dysfunction.
    Rossi R, Gödde A, Kleinebrand A, Rath B, Jürgens H.
    Ren Fail; 1995 Sep; 17(5):551-7. PubMed ID: 8570867
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ifosfamide-induced Fanconi syndrome.
    Garcia AA.
    Ann Pharmacother; 1995 Jun; 29(6):590-1. PubMed ID: 7663031
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
    Ashraf MS, Skinner R, English MW, Craft AW, Pearson AD.
    Med Pediatr Oncol; 1997 Jan; 28(1):62-4. PubMed ID: 8950339
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
    Ho PT, Zimmerman K, Wexler LH, Blaney S, Jarosinski P, Weaver-McClure L, Izraeli S, Balis FM.
    Cancer; 1995 Dec 15; 76(12):2557-64. PubMed ID: 8625085
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.
    Burk CD, Restaino I, Kaplan BS, Meadows AT.
    J Pediatr; 1990 Aug 15; 117(2 Pt 1):331-5. PubMed ID: 2166154
    [Abstract] [Full Text] [Related]

  • 18. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.
    Rossi R, Helmchen U, Schellong G.
    Eur J Pediatr; 1992 May 15; 151(5):384-7. PubMed ID: 1396897
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.